NO20050668L - 7,8,9,10-tetrahydro-6H-azepino6,7,8,9-tetrahydro-pyrido og 2,3-dihydro-2H-pyrrolo [2,1-B]-kinazolinon-derivater - Google Patents
7,8,9,10-tetrahydro-6H-azepino6,7,8,9-tetrahydro-pyrido og 2,3-dihydro-2H-pyrrolo [2,1-B]-kinazolinon-derivaterInfo
- Publication number
- NO20050668L NO20050668L NO20050668A NO20050668A NO20050668L NO 20050668 L NO20050668 L NO 20050668L NO 20050668 A NO20050668 A NO 20050668A NO 20050668 A NO20050668 A NO 20050668A NO 20050668 L NO20050668 L NO 20050668L
- Authority
- NO
- Norway
- Prior art keywords
- tetrahydro
- pyrido
- pyrrolo
- dihydro
- azepino6
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Cardiology (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Det beskrives nye 7,8,9,10-tetrahydro-6W-azepino-, 6,7,8,9-tetrahydro-pyrido- og 2,3-dihydro-2W-pyrrolo[2,l-fe]-kina2olinoh-derivater med fonnel (I) og anvendelse av dem som aktive bestanddeler ved fremstilling av farmasøytiske preparater. Det beskrives også beslektede aspekter omfattende fremgangsmåter for fremstilling av forbindelsene, farmasøytiske preparater inneholdende én eller flere av forbindelsene og spesielt anvendelse av dem som oreksin-reseptorantagonister.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP0207608 | 2002-07-09 | ||
PCT/EP2003/007297 WO2004004733A1 (en) | 2002-07-09 | 2003-07-08 | 7,8,9,10-tetrahydro-6h-azepino, 6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2h-pyrrolo[2,1-b]-quinazolinone derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20050668L true NO20050668L (no) | 2005-04-05 |
Family
ID=30011039
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20050668A NO20050668L (no) | 2002-07-09 | 2005-02-08 | 7,8,9,10-tetrahydro-6H-azepino6,7,8,9-tetrahydro-pyrido og 2,3-dihydro-2H-pyrrolo [2,1-B]-kinazolinon-derivater |
Country Status (16)
Country | Link |
---|---|
US (1) | US7067519B2 (no) |
EP (1) | EP1521583B1 (no) |
JP (1) | JP4498922B2 (no) |
CN (1) | CN1556705B (no) |
AU (1) | AU2003246657A1 (no) |
CA (1) | CA2460051A1 (no) |
DE (1) | DE60311101T2 (no) |
ES (1) | ES2278197T3 (no) |
IL (1) | IL166100A0 (no) |
MX (1) | MXPA04002269A (no) |
NO (1) | NO20050668L (no) |
NZ (1) | NZ538029A (no) |
PL (1) | PL373223A1 (no) |
RU (1) | RU2005103398A (no) |
WO (1) | WO2004004733A1 (no) |
ZA (1) | ZA200500026B (no) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE602004011204T2 (de) * | 2003-04-28 | 2008-12-24 | Actelion Pharmaceuticals Ltd. | Quinoxalin-3-on-verdindungen als orexin-rezeptor antagonisten. |
US7678150B2 (en) * | 2004-06-15 | 2010-03-16 | Tornier Sas | Total shoulder prosthesis of an inverted type |
US8618102B2 (en) | 2006-07-14 | 2013-12-31 | Merck Sharp & Dohme Corp. | Bridged diazepan orexin receptor antagonists |
EP2059520B1 (en) * | 2006-08-28 | 2010-02-24 | Actelion Pharmaceuticals Ltd. | 1,4,5,6,7,8-hexahydro-i,2,5-triaza-azulene derivatives as orexin receptor antagonists |
PE20081229A1 (es) | 2006-12-01 | 2008-08-28 | Merck & Co Inc | Antagonistas de receptor de orexina de diazepam sustituido |
CA2669561A1 (en) | 2006-12-22 | 2008-07-03 | Actelion Pharmaceuticals Ltd | 5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine derivatives |
EP2150114A4 (en) | 2007-05-18 | 2012-01-18 | Merck Sharp & Dohme | OXO-BRIDGED DIAZEPANOREXINE RECEPTOR ANTAGONISTS |
CA2687230A1 (en) | 2007-05-23 | 2008-12-11 | Merck & Co., Inc. | Cyclopropyl pyrrolidine orexin receptor antagonists |
ES2379744T3 (es) | 2007-05-23 | 2012-05-03 | Merck Sharp & Dohme Corp. | Antagonistas de piridil-piperidina de los receptores de orexinas |
EP2161266A1 (en) | 2008-08-22 | 2010-03-10 | EVOTEC Neurosciences GmbH | Benzofuran derivatives as orexin receptor antagonists |
WO2010047982A1 (en) | 2008-10-22 | 2010-04-29 | Merck Sharp & Dohme Corp. | Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
JP5557845B2 (ja) | 2008-10-31 | 2014-07-23 | メルク・シャープ・アンド・ドーム・コーポレーション | 糖尿病用剤として有用な新規環状ベンゾイミダゾール誘導体 |
CN102781942B (zh) * | 2009-10-23 | 2015-09-23 | 詹森药业有限公司 | 用作食欲肽受体调节剂的二取代八氢吡咯并[3,4-c]吡咯 |
WO2011050200A1 (en) | 2009-10-23 | 2011-04-28 | Janssen Pharmaceutica Nv | Fused heterocyclic compounds as orexin receptor modulators |
WO2011050202A1 (en) | 2009-10-23 | 2011-04-28 | Janssen Pharmaceutica Nv | Fused heterocyclic compounds as orexin receptor modulators |
EP2538784B1 (en) | 2010-02-25 | 2015-09-09 | Merck Sharp & Dohme Corp. | Benzimidazole derivatives useful anti-diabetic agents |
WO2011138266A1 (en) | 2010-05-03 | 2011-11-10 | Evotec Ag | Indolizine and imidazopyridine derivatives as orexin receptor antagonists |
WO2011138265A2 (en) | 2010-05-03 | 2011-11-10 | Evotec Ag | Indole and indazole derivatives as orexin receptor antagonists |
EP2677869B1 (en) | 2011-02-25 | 2017-11-08 | Merck Sharp & Dohme Corp. | Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents |
WO2012145581A1 (en) | 2011-04-20 | 2012-10-26 | Janssen Pharmaceutica Nv | Disubstituted octahy-dropyrrolo [3,4-c] pyrroles as orexin receptor modulators |
CA2841897A1 (en) * | 2011-07-13 | 2013-01-17 | Santen Pharmaceutical Co., Ltd. | Novel compound having parp inhibitory activity |
AR088352A1 (es) | 2011-10-19 | 2014-05-28 | Merck Sharp & Dohme | Antagonistas del receptor de 2-piridiloxi-4-nitrilo orexina |
EP2811997B1 (en) | 2012-02-07 | 2018-04-11 | Eolas Therapeutics Inc. | Substituted prolines/piperidines as orexin receptor antagonists |
US9440982B2 (en) | 2012-02-07 | 2016-09-13 | Eolas Therapeutics, Inc. | Substituted prolines/piperidines as orexin receptor antagonists |
RU2015106909A (ru) | 2012-08-02 | 2016-09-27 | Мерк Шарп И Доум Корп. | Антидиабетические трициклические соединения |
CA2898482A1 (en) | 2013-02-22 | 2014-08-28 | Linda L. Brockunier | Antidiabetic bicyclic compounds |
WO2014139388A1 (en) | 2013-03-14 | 2014-09-18 | Merck Sharp & Dohme Corp. | Novel indole derivatives useful as anti-diabetic agents |
WO2015051496A1 (en) | 2013-10-08 | 2015-04-16 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
US10221170B2 (en) | 2014-08-13 | 2019-03-05 | Eolas Therapeutics, Inc. | Difluoropyrrolidines as orexin receptor modulators |
HUE059280T2 (hu) | 2016-02-12 | 2022-11-28 | Astrazeneca Ab | Halogén-szubsztituált piperidinek mint orexin receptor modulátorok |
CR20180433A (es) | 2016-03-10 | 2018-11-07 | Janssen Pharmaceutica Nv | Métodos para tratar la depresión con antagonistas del receptor de orexina-2 |
US20190151304A1 (en) | 2016-05-10 | 2019-05-23 | Inserm (Institut National De La Santé Et De La Rechercjae Médicale | Methods and pharmaceutical compositions for the treatment of autoimmune inflammatory |
EP3551176A4 (en) | 2016-12-06 | 2020-06-24 | Merck Sharp & Dohme Corp. | ANTIDIABETIC HETEROCYCLIC COMPOUNDS |
EP3558298A4 (en) | 2016-12-20 | 2020-08-05 | Merck Sharp & Dohme Corp. | ANTIDIABETIC SPIROCHROMAN COMPOUNDS |
EP3661502A4 (en) | 2017-08-03 | 2020-12-02 | Galectin Sciences, LLC | COMPOUNDS FOR THE PREVENTION AND TREATMENT OF MEDICAL CONDITIONS AND THEIR USES |
WO2020122092A1 (ja) * | 2018-12-12 | 2020-06-18 | 武田薬品工業株式会社 | 複素環化合物 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU173438B (hu) * | 1975-11-27 | 1979-05-28 | Chinoin Gyogyszer Es Vegyeszet | Sposob poluchenija novykh proizvodnykh 4-okso-1,6,7,8-/tetragidro-4h-pirido/1,2/pirimidina s zaderzhivajuhhejj vozgoranie aktivnot'ju i protivosvertivajuhhem effektom |
HU191192B (en) * | 1982-11-16 | 1987-01-28 | Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu | Process for producing new azepino /1,2-a/ pyrimidine derivatives of bronchodilating activity and acid additional salts thereof and pharmaceiutical compositions containing them |
US4678499A (en) * | 1985-03-11 | 1987-07-07 | E. I. Du Pont De Nemours And Company | Herbicidal sulfonamides |
US5753664A (en) * | 1995-03-16 | 1998-05-19 | Takeda Chemical Industries, Ltd. | Heterocyclic compounds, their production and use |
CA2274539A1 (en) * | 1996-12-09 | 1998-06-18 | Warner-Lambert Company | Antibacterial materials comprising a 4-oxo-1,3-benzoxazine ring structure |
AR016817A1 (es) | 1997-08-14 | 2001-08-01 | Smithkline Beecham Plc | Derivados de fenilurea o feniltiourea, procedimiento para su preparacion, coleccion de compuestos, compuestos intermediarios, composicion farmaceutica,metodo de tratamiento y uso de dichos compuestos para la manufactura de un medicamento |
CA2331735A1 (en) | 1998-05-08 | 1999-11-18 | Smithkline Beecham P.L.C. | Phenylurea and phenylthio urea derivatives |
US6699879B1 (en) | 1999-02-12 | 2004-03-02 | Smithkline Beecham P.L.C. | Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonists |
WO2000047576A1 (en) | 1999-02-12 | 2000-08-17 | Smithkline Beecham Plc | Cinnamide derivatives as orexin-1 receptors antagonists |
AU2910600A (en) | 1999-02-12 | 2000-08-29 | Smithkline Beecham Plc | Phenyl urea and phenyl thiourea derivatives |
DE19906975B4 (de) * | 1999-02-19 | 2004-04-15 | Lts Lohmann Therapie-Systeme Ag | Arzneiform zur Behandlung von Alzheimer'scher Demenz |
JP2003525897A (ja) * | 2000-03-06 | 2003-09-02 | アストラゼネカ アクチボラグ | 治 療 |
CA2408343A1 (en) | 2000-05-11 | 2002-11-07 | Banyu Pharmaceutical Co., Ltd. | N-acyltetrahydroisoquinoline derivatives |
PT1289955E (pt) | 2000-06-16 | 2005-08-31 | Smithkline Beecham Plc | Piperidinas para utilizacao como antagonistas dos receptores da orexina |
AU2002224885A1 (en) | 2000-11-28 | 2002-06-11 | Smithkline Beecham Plc | Morpholine derivatives as antagonists of orexin receptors |
GB0121214D0 (en) * | 2001-08-31 | 2001-10-24 | Btg Int Ltd | Synthetic method |
US6825184B2 (en) * | 2001-10-18 | 2004-11-30 | Boehringer Ingelheim Pharmaceuticals, Inc. | 1,4-Disubstituted benzo-fused urea compounds |
US6676976B2 (en) * | 2002-03-21 | 2004-01-13 | Council Of Scientific And Industrial Research | Process for the production of vasicine |
-
2003
- 2003-07-08 MX MXPA04002269A patent/MXPA04002269A/es unknown
- 2003-07-08 DE DE60311101T patent/DE60311101T2/de not_active Expired - Lifetime
- 2003-07-08 US US10/489,350 patent/US7067519B2/en not_active Expired - Fee Related
- 2003-07-08 WO PCT/EP2003/007297 patent/WO2004004733A1/en active IP Right Grant
- 2003-07-08 NZ NZ538029A patent/NZ538029A/en unknown
- 2003-07-08 PL PL03373223A patent/PL373223A1/xx not_active Application Discontinuation
- 2003-07-08 EP EP03762653A patent/EP1521583B1/en not_active Expired - Lifetime
- 2003-07-08 CN CN038011042A patent/CN1556705B/zh not_active Expired - Fee Related
- 2003-07-08 AU AU2003246657A patent/AU2003246657A1/en not_active Abandoned
- 2003-07-08 ES ES03762653T patent/ES2278197T3/es not_active Expired - Lifetime
- 2003-07-08 RU RU2005103398/04A patent/RU2005103398A/ru not_active Application Discontinuation
- 2003-07-08 JP JP2004518740A patent/JP4498922B2/ja not_active Expired - Fee Related
- 2003-07-08 CA CA002460051A patent/CA2460051A1/en not_active Abandoned
-
2005
- 2005-01-03 ZA ZA200500026A patent/ZA200500026B/en unknown
- 2005-01-03 IL IL16610005A patent/IL166100A0/xx unknown
- 2005-02-08 NO NO20050668A patent/NO20050668L/no unknown
Also Published As
Publication number | Publication date |
---|---|
PL373223A1 (en) | 2005-08-22 |
WO2004004733A1 (en) | 2004-01-15 |
JP2005532381A (ja) | 2005-10-27 |
EP1521583A1 (en) | 2005-04-13 |
ES2278197T3 (es) | 2007-08-01 |
JP4498922B2 (ja) | 2010-07-07 |
CA2460051A1 (en) | 2004-01-15 |
AU2003246657A1 (en) | 2004-01-23 |
ZA200500026B (en) | 2005-10-20 |
EP1521583B1 (en) | 2007-01-10 |
CN1556705B (zh) | 2010-04-28 |
MXPA04002269A (es) | 2004-06-29 |
DE60311101D1 (de) | 2007-02-22 |
DE60311101T2 (de) | 2007-06-21 |
US7067519B2 (en) | 2006-06-27 |
IL166100A0 (en) | 2006-01-15 |
NZ538029A (en) | 2006-08-31 |
CN1556705A (zh) | 2004-12-22 |
RU2005103398A (ru) | 2006-06-27 |
US20050009852A1 (en) | 2005-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20050668L (no) | 7,8,9,10-tetrahydro-6H-azepino6,7,8,9-tetrahydro-pyrido og 2,3-dihydro-2H-pyrrolo [2,1-B]-kinazolinon-derivater | |
NO20050932L (no) | 1-pyridin-4-yl-ureaderivater | |
NO20051102L (no) | Sulfonylamino-eddiksyre-derivater | |
NO20032905D0 (no) | Nye benzodiazepiner og beslektede heterocykliske derivater som er anvendelige som orexinreseptorantagonister | |
ATE301653T1 (de) | Pyrazolopyridine | |
ATE286500T1 (de) | 1,2,3,4-tetrahydroisochinolin-derivate | |
BRPI0408681A (pt) | compostos, composições farmacêuticas, uso de um derivado da 1,2,3,4-tetraidroisoquinolina, método para tratar ou prevenir doenças, processo para a manufatura de composições farmacêuticas, e, uso de um ou mais compostos | |
NO20042844L (no) | 4-(piperidyl- og pyrrolidyl-alkyl-ureido)-kinoliner som uprotensin II reseptor-antagonister | |
DE60204452D1 (de) | Pyrazolo[1,5]pyridinderivate | |
DE60212949D1 (de) | Antivirale pyrazolopyridin verbindungen | |
NO20063231L (no) | Pyrido[2,3-D]pyrimidin-2,4-diaminer som PDE 2 inhibitorer | |
NO20061395L (no) | Nye pyridinderivater | |
NO20034230L (no) | 1,2,3,4-tetrahydroisokinolin-derivater som urotensin II reseptor-antagonister | |
WO2003095455A3 (en) | Substituted pyrazolopyrimidines | |
NO20055623L (no) | Azabicyklononenderivater | |
CO5631443A2 (es) | Derivados de 7-aril-3,9-diazabiciclo (3.3.1) non-6-eno y su uso como inhibidores de renina en el tratamiento de enfermedades de hipertension, cardiovasculares o renales | |
ATE300541T1 (de) | Pyrazolopyridinderivate | |
NO20055624L (no) | Tropanderivater og deres anvendelse som Ace-inhibitorer | |
NO20004089L (no) | Nye triazolo(4,5-d)pyrimidinforbindelser | |
ATE383345T1 (de) | Quinoxalin-3-on-verdindungen als orexin-rezeptor antagonisten. | |
BR0316724A (pt) | Compostos, uso de um ou mais compostos, e, processo para a fabricação de composições farmacêuticas | |
WO2002024665A8 (en) | Arylalkane-sulfonamides having endothelin-antagonist activity | |
NO20040821L (no) | 3-substituerte 6,7-dihydroksytetrahydroisokinolinderivater for andvendelse som antibakterielle midler. | |
ATE274515T1 (de) | Pyrazolopyridinderivate | |
DE60222465D1 (de) | Pyrazolopyridin-derivate als antiherpesmittel |